
Sweeping New FTC Rules Could Chill Healthcare Mergers and Acquisitions
Proposed rule would require businesses to undergo even more stringent review to secure regulatory approval for such deals.
Proposed rule would require businesses to undergo even more stringent review to secure regulatory approval for such deals.
The recent 8-1 decision expands the DOJ’s power to request such cases be thrown out.
A recent SCOTUS ruling on a healthcare fraud case could help defend labs against baseless whistleblower cases.
Ruling could spell good news for labs and other healthcare providers targeted by whistleblowers in False Claims Act qui tam lawsuits.
False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.